Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Fusion Pharmaceuticals Inc. - Common Shares
(NQ:
FUSN
)
21.55
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Fusion Pharmaceuticals Inc. - Common Shares
< Previous
1
2
3
4
Next >
Why Fusion Pharmaceuticals Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket
↗
February 14, 2023
Gainers
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
↗
February 14, 2023
It's time to start another day of trading with a breakdown of the biggest pre-market stock movers investors need to watch for Tuesday!
Via
InvestorPlace
Fusion Pharmaceuticals's Return On Capital Employed Overview
↗
December 06, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 30, 2022
↗
November 30, 2022
Via
Benzinga
Recap: Fusion Pharmaceuticals Q1 Earnings
↗
May 10, 2022
Fusion Pharmaceuticals (NASDAQ:FUSN) reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
10 Best Stocks to Buy Now According to Jeffrey Diehl’s Adams Street Partners
↗
October 05, 2022
In this article, we will be taking a look at some of the top stocks in the portfolio of Jeffrey Diehl.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2022
↗
September 16, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
September 14, 2022
Via
Benzinga
Why Vintage Wine Estates Shares Tumbled 40%; Here Are 70 Biggest Movers From Yesterday
↗
September 15, 2022
Gainers AMTD Digital Inc. (NYSE: HKD) shares jumped 311.8% to settle at $189.42 on Wednesday as the stock experienced a resurgence in momentum despite a lack of fundamental news.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
↗
September 07, 2022
Upgrades
Via
Benzinga
$1.7 Million Bet On Offerpad Solutions? Check Out These 3 Penny Stocks Insiders Are Buying
↗
August 12, 2022
U.S. producer prices dropped 0.5% month-over-month in July, following a revised 1% increase in the previous month. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
↗
August 10, 2022
During Wednesday, 52 stocks hit new 52-week lows.
Via
Benzinga
Fusion Pharmaceuticals: Q2 Earnings Insights
↗
August 09, 2022
Fusion Pharmaceuticals (NASDAQ:FUSN) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
↗
August 08, 2022
On Monday, 15 companies hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
↗
August 09, 2022
On Tuesday, 73 companies hit new 52-week lows.
Via
Benzinga
The Daily Biotech Pulse: F-Star Therapeutics Buyout, Orphan Drug Tag For VBI's Brain Cancer Vaccine, Xenon's Epilepsy Candidate Shows Promise
↗
June 23, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2022
↗
July 06, 2022
Upgrades
Via
Benzinga
Looking Into Fusion Pharmaceuticals's Return On Capital Employed
↗
June 10, 2022
Fusion Pharmaceuticals (NASDAQ:FUSN) brought in sales totaling $585.00 thousand during Q1 according to data provided by Benzinga Pro. However, earnings decreased 15.51%, resulting in a loss of $19.91...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
April 27, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
↗
June 28, 2022
On Tuesday, 87 companies hit new 52-week lows.
Via
Benzinga
This Company Is Making Progress In Its Fight Against Rare, Terminal Cancers
↗
March 22, 2022
Photo by National Cancer Institute on Unsplash
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
↗
June 27, 2022
During Monday's session, 77 companies made new 52-week lows.
Via
Benzinga
"Our Mission Is To Eliminate Cancer" – Here's How This Company Is Using AI In An Attempt To Save Lives
↗
January 26, 2022
Photo by National Cancer Institute on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
January 20, 2022
Gainers Baudax Bio (NASDAQ:BXRX) stock rose 32.2% to $0.26 during Thursday's pre-market session. The company's market cap stands at $21.9 million. Aptorum Group (...
Via
Benzinga
52 Biggest Movers From Yesterday
↗
January 20, 2022
Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares surged 65.7% to close at $25.92 on Wednesday after the company announced it will be acquired by UCB for approximately $1.9 billion. G...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
January 19, 2022
Gainers Zogenix (NASDAQ:ZGNX) shares moved upwards by 67.2% to $26.15 during Wednesday's regular session. As of 12:30 EST, Zogenix's stock is trading at a volume...
Via
Benzinga
5 Value Stocks In The Healthcare Sector
↗
September 06, 2021
What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 26, 2021
↗
August 26, 2021
Upgrades Scotiabank upgraded the previous rating for Enerplus Corp (NYSE:
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
July 30, 2021
Gainers Erytech Pharma (NASDAQ:ERYP) shares moved upwards by 79.56% to $7.38 during Friday's pre-market session. The market value of their outstanding shares is at $...
Via
Benzinga
44 Stocks Moving In Thursday's Mid-Day Session
↗
July 29, 2021
Gainers NanoVibronix, Inc. (NASDAQ: NAOV) shares jumped 47.6% to $2.8198 after the company announced it received registration approval for UroShield from TGA Australia....
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
